相关实验视频

Updated: Jun 13, 2025

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles

Published on: June 2, 2023

伊索克尔提因通过Nrf2/NF-κB轴改善骨关节炎:一个体外和体外研究

He Yu¹, Junsheng Lou², Libin Ni¹

¹Department of Orthopaedics, Zhejiang Hospital, Zhejiang, Hangzhou, China.

Chemical biology & drug design

|September 9, 2024

概括

天然化合物伊索克尔素通过调节Nrf2/NF-κB信号通路,有效降低骨关节炎 (OA) 中的炎症和细胞外基质降解,显示为潜在OA治疗的前景.

科学领域:

生物化学生化学
药理学药理学是指药理学的学科.
细胞生物学细胞生物学

背景情况:

骨关节炎 (OA) 是一种退行性关节疾病,治疗选择有限.
冠状细胞功能障碍和细胞外矩阵 (ECM) 降解驱动OA病理.
易索克尔塞是一种黄类化合物,在各种疾病中表现出抗炎作用.

研究的目的:

为了研究异二在骨关节炎中的治疗潜力.
阐明底层的分子机制isoquercetin的作用对冠状细胞和OA.
在体内OA模型中评估isoquercetin的疗效.

主要方法:

西部斑块,qRT-PCR和ELISA用于分析分子标记物.
核血分离技术用于研究信号通路.
在体内研究使用X射线和SAFRANIN-O (SO) 染色在小鼠OA模型.

主要成果:

伊索克尔塞丁抑制了IL-1β诱导的ADAMTS5,MMP13,COX-2,iNOS和IL-6在红细胞中的增加.
异甲调节了Nrf2和NF-κB信号通路.
在小鼠OA模型中,关节内异素注射减少了软骨降解.

结论:

伊索克尔塞丁通过抑制炎症和ECM降解,表现出冠状腺保护作用.
伊索克尔塞丁在瘤中具有治疗作用,涉及对Nrf2/NF-κB信号轴的调节.
伊索克尔塞丁是骨关节炎治疗的有前途的治疗候选药物.

关键词:

在 NF-κBB 中.冠状腺细胞 (chondrocytes) 是一种体内细胞.这是一种炎症炎症炎症炎症.艾索奎尔塞廷是一种异素.骨关节炎是一种关节炎.

更多相关视频

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Published on: March 18, 2022

Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective

Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective

Published on: January 12, 2024

相关概念视频

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...